Novocure Limited (NVCR)

NASDAQ: NVCR · IEX Real-Time Price · USD
-0.73 (-0.91%)
Aug 19, 2022 3:59 PM EDT - Market closed

Total Valuation

Novocure has a market cap or net worth of $8.54 billion. The enterprise value is $8.16 billion.

Market Cap 8.54B
Enterprise Value 8.16B

Important Dates

The latest earnings date was Thursday, July 28, 2022, before market open.

Last Earnings Date Jul 28, 2022
Ex-Dividend Date n/a

Share Statistics

Novocure has 107.67 million shares outstanding. The number of shares has increased by 1.10% in one year.

Shares Outstanding 107.67M
Shares Change (YoY) +1.10%
Shares Change (QoQ) +0.42%
Owned by Insiders (%) 13.27%
Owned by Institutions (%) 78.11%
Float 89.99M

Valuation Ratios

PE Ratio n/a
Forward PE 909.09
PS Ratio 15.66
Forward PS 14.14
PB Ratio 19.33
P/FCF Ratio 354.43
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 14.97
EV / EBIT n/a
EV / FCF 338.98

Financial Position

The company has a current ratio of 8.08, with a Debt / Equity ratio of 1.31.

Current Ratio 8.08
Quick Ratio 7.87
Debt / Equity 1.31
Debt / EBITDA n/a
Debt / FCF 23.97

Financial Efficiency

Return on equity (ROE) is -16.00% and return on invested capital (ROIC) is -4.40%.

Return on Equity (ROE) -16.00%
Return on Assets (ROA) -6.00%
Return on Capital (ROIC) -4.40%
Revenue Per Employee $467,208
Profits Per Employee -$58,472
Employee Count 1,167
Asset Turnover 0.48
Inventory Turnover 4.13


In the past 12 months, Novocure has paid $6.26 million in taxes.

Income Tax 6.26M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -39.65% in the last 52 weeks. The beta is 0.87, so Novocure's price volatility has been lower than the market average.

Beta (1Y) 0.87
52-Week Price Change -39.65%
50-Day Moving Average 74.47
200-Day Moving Average 75.42
Average Volume (30 Days) 634,445

Short Selling Information

The latest short interest is 6.78 million, so 6.29% of the outstanding shares have been sold short.

Short Interest 6.78M
Short % of Shares Out 6.29%
Short % of Float 7.53%
Short Ratio (days to cover) 14.37

Income Statement

In the last 12 months, Novocure had revenue of $545.23 million and -68.24 million in losses. Earnings per share was -$0.57.

Revenue 545.23M
Gross Profit 429.11M
Operating Income -53.88M
Pretax Income -61.98M
Net Income -68.24M
EBITDA -43.22M
EBIT -53.88M
Earnings Per Share (EPS) -$0.57
Full Income Statement

Balance Sheet

The company has $949.27 million in cash and $577.22 million in debt, giving a net cash position of $372.04 million or $3.46 per share.

Cash & Cash Equivalents 949.27M
Total Debt 577.22M
Net Cash 372.04M
Net Cash Per Share $3.46
Book Value 441.67M
Book Value Per Share 4.10
Working Capital 959.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $50.88 million and capital expenditures -$26.80 million, giving a free cash flow of $24.08 million.

Operating Cash Flow 50.88M
Capital Expenditures -26.80M
Free Cash Flow 24.08M
FCF Per Share $0.22
Full Cash Flow Statement


Gross margin is 78.70%, with operating and profit margins of -9.88% and -12.52%.

Gross Margin 78.70%
Operating Margin -9.88%
Pretax Margin -11.37%
Profit Margin -12.52%
EBITDA Margin -7.93%
EBIT Margin -9.88%
FCF Margin 4.42%

Dividends & Yields

Novocure does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -0.80%
FCF Yield 0.28%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -1.10%
Shareholder Yield -1.10%
Dividend Details

Analyst Forecast

The average price target for Novocure is $96.14, which is 21.27% higher than the current price. The consensus rating is "Buy".

Price Target $96.14
Price Target Difference 21.27%
Analyst Consensus Buy
Analyst Count 14
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a